Carcinoma of unknown primary (CUP)

Area of Science:

• Oncology
• Pathology

Background:

• Carcinoma of unknown primary (CUP) represents 3-5% of all human malignancies and is a frequent diagnosis worldwide.
• Patients present with metastatic disease, but the primary tumor site remains elusive despite extensive diagnostic work-up.

Purpose of the Study:

• To review the diagnostic challenges and prognostic implications of Carcinoma of Unknown Primary.
• To identify favorable clinicopathological subsets of CUP that may benefit from specific treatments.

Main Methods:

• Review of histopathology and modern imaging techniques for CUP diagnosis.
• Discussion of molecular diagnostic tools like DNA microarrays.
• Analysis of clinicopathological features defining favorable and unfavorable CUP subsets.

Main Results:

• The primary tumor in CUP remains undetected in most cases, even with advanced diagnostics.
• Certain CUP subtypes, including mediastinal/retroperitoneal nodes, peritoneal papillary serous adenocarcinomatosis in females, neuroendocrine carcinomas, and specific nodal presentations, are considered favorable.
• Patients in favorable subsets may respond to platinum-based chemotherapy or locoregional treatments.

Conclusions:

• Despite diagnostic challenges, specific clinicopathological entities within CUP offer prognostic information.
• Identification of favorable CUP subsets is crucial for tailoring treatment strategies and improving outcomes.
• Unfavorable CUP subsets are associated with a poorer prognosis, highlighting the need for further research.